30 May 2023 - The Government welcomes the Therapeutic Goods Administration’s approval of a ‘plasma pathway’, allowing a larger pool of ...
15 July 2022 - Xembify is yet another presentation of human immunoglobulin. ...
12 May 2021 - The TGA has deemed it to be a new biological entity. Others will beg to differ. ...
6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...
6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...
6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...
8 April 2020 - It sounds like a pitch for a sci-fi thriller — using genetically modified cows to fight ...
10 July 2017 - Australian vaccines and blood products developer CSL says it will vigorously fight a patent infringement claim ...
19 April 2017 - In clinical trials, patients undergoing prophylaxis with Afstyla experienced a median annualised spontaneous bleeding rate of ...
17 November 2016 - The TGA has approved Grifols' new alfa-1-proteinase inhibitor. ...
27 September 2016 - CSL Behring's Idelvion is now approved by the TGA. ...
15 September 2016 - The TGA has approved a new use for Biogen's Alprolix. ...
17 June 2016 - The TGA has published an AusPAR for Octapharma's Nuwiq (simoctocog alfa). ...
2 May 2016 - The TGA registered two new chemical entities (medicines) and two new blood products in April 2016. ...